Combined chemotherapy with VM 26 and BCNU for recurrent malignant gliomas after operation and irradiation.
The preliminary results of a combined chemotherapy trial with VM 26 and BCNU for recurrent malignant gliomas are presented. Four patients out of seven responded favourably to this treatment. Toxicity was mild and reversible.